Multi-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-Oncology

Abstract

The tumor microenvironment (TME) is a multifaceted ecosystem characterized by profound cellular heterogeneity, dynamicity, and complex intercellular cross-talk. The striking responses obtained with immune checkpoint blockers, i.e., antibodies targeting immune-cell regulators to boost antitumor immunity, have demonstrated the enormous potential of anticancer treatments that target TME components other than tumor cells. However, as checkpoint blockade is currently beneficial only to a limited fraction of patients, there is an urgent need to understand the mechanisms orchestrating the immune response in the TME to guide the rational design of more effective anticancer therapies. In this Mini Review, we give an overview of the methodologies that allow studying the heterogeneity of the TME from multi-omics data generated from bulk samples, single cells, or images of tumor-tissue slides. These include approaches for the characterization of the different cell phenotypes and for the reconstruction of their spatial organization and inter-cellular cross-talk. We discuss how this broader vision of the cellular heterogeneity and plasticity of tumors, which is emerging thanks to these methodologies, offers the opportunity to rationally design precision immuno-oncology treatments. These developments are fundamental to overcome the current limitations of targeted agents and checkpoint blockers and to bring long-term clinical benefits to a larger fraction of cancer patients.

Artificial Intelligence (AI)-Based Systems Biology Approaches in Multi-Omics Data Analysis of Cancer

“…The expression fold change of enriched genes and proteins predicts disease prognosis and determines treatment ( 68 , 69 ). The multi-omics profile of the tumor microenvironment (TME) provides insights on intra-tumor heterogeneity paving the path of precision immune-oncology ( 70 ).…”

Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome‐driven neoplasms

“…Owing to the advance and cost reduction in high‐throughput sequencing technologies and analytical platforms for large‐scale data, multi‐omics data are increasingly available for epidemiology studies . Sequencing‐based analyses including RNA transcriptomic sequencing, metagenomic analyses and single‐cell sequencing will allow us to examine the complex relationship of the microbiota, immune cells, and tumour cells in a more comprehensive fashion.…”

Editorial: Multi-omic Data Integration in Oncology

“…However, the majority of molecular aberrations identified in cancers have synergic interactions in many aspects of cell signaling beyond the genome. The complexity of cancers cross cell boundaries especially studying the tumor microenvironment as a heterogeneous and dynamic network of interacting cells (1), one of the new hot topics for anticancer treatment development. In this scenario, multi-omic technologies and single-cell data can shed light on these interactions by generating high-throughput datasets portraying the genomes, transcriptomes, proteomes, metabolomes, and epigenomes of tumors.…”